• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者中,升高的 FGF23 和磷与冠状动脉钙化有关。

Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.

机构信息

Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX, 77030, USA.

出版信息

Pediatr Nephrol. 2011 Jun;26(6):945-51. doi: 10.1007/s00467-011-1822-0. Epub 2011 Feb 27.

DOI:10.1007/s00467-011-1822-0
PMID:21359960
Abstract

Increased mortality of adult chronic hemodialysis (HD) patients is associated with coronary calcifications (CC), increased serum phosphorus (P), use of calcium (Ca)-containing P-binders, and vitamin D deficiency. Serum concentration of fibroblast growth factor 23 (FGF 23) is markedly elevated in adults receiving dialysis and is independently associated with increased mortality. Although coronary calcifications have been described in pediatric and adult HD patients, no significant association between serum FGF 23 and CC has been reported. In our study, 5/16 patients had CC. Patients with CC were older, had longer dialysis vintage and higher serum P. Serum Ca, total PTH, elemental Ca intake, and calcitriol doses were not different for CC patients. Serum FGF 23 levels were markedly elevated in all patients (mean 4,024, range 874-8,253), but significantly higher in patients with CC (4,247 ± 10,35 vs 2,427 ± 11,92, p = 0.01) and positively correlated with Agatston calcification score (r = 0.69, p = 0.003) and serum P (r = 0.49, p = 0.05). Using multivariate analysis, serum FGF 23 and serum P remained the most significant factors associated with Agatston score. This study confirms the occurrence of CC in pediatric HD patients and is the first to show a significant association between CC and elevated serum FGF 23 in children.

摘要

在接受透析治疗的成年人中,成纤维细胞生长因子 23(FGF 23)的血清浓度明显升高,并且与死亡率升高独立相关。尽管已经在儿科和成年 HD 患者中描述了冠状动脉钙化(CC),但尚未报道 FGF 23 与 CC 之间存在显著相关性。在我们的研究中,有 5/16 例患者存在 CC。患有 CC 的患者年龄更大,透析时间更长,血清 P 更高。CC 患者的血清 Ca、总 PTH、元素 Ca 摄入量和骨化三醇剂量没有差异。所有患者的血清 FGF 23 水平均明显升高(平均值为 4024,范围为 874-8253),但 CC 患者的水平明显更高(4247 ± 1035 比 2427 ± 1192,p = 0.01),与 Agatston 钙化评分呈正相关(r = 0.69,p = 0.003)和血清 P(r = 0.49,p = 0.05)。使用多元分析,血清 FGF 23 和血清 P 仍然是与 Agatston 评分最显著相关的因素。本研究证实了 CC 在儿科 HD 患者中的发生,并首次显示 CC 与儿童血清 FGF 23 升高之间存在显著相关性。

相似文献

1
Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.血液透析患者中,升高的 FGF23 和磷与冠状动脉钙化有关。
Pediatr Nephrol. 2011 Jun;26(6):945-51. doi: 10.1007/s00467-011-1822-0. Epub 2011 Feb 27.
2
High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications.高血清磷和FGF 23水平与冠状动脉钙化进展相关。
Pediatr Nephrol. 2014 Jan;29(1):103-9. doi: 10.1007/s00467-013-2575-8. Epub 2013 Aug 8.
3
Cardiac calcifications are more prevalent in children receiving hemodialysis than peritoneal dialysis.接受血液透析的儿童比接受腹膜透析的儿童更容易出现心脏钙化。
Clin Nephrol. 2014 Apr;81(4):231-7. doi: 10.5414/cn108178.
4
Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis.接受长期血液透析的儿科患者的营养不良-炎症-冠状动脉钙化
Hemodial Int. 2010 Jul;14(3):263-9. doi: 10.1111/j.1542-4758.2010.00442.x. Epub 2009 Nov 17.
5
FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.在血液透析患者中,成纤维细胞生长因子23(FGF - 23)水平与血管钙化相关,但与动脉粥样硬化无关。
Int Urol Nephrol. 2016 Apr;48(4):609-17. doi: 10.1007/s11255-016-1231-1. Epub 2016 Feb 10.
6
Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23.组织学评估的外周动脉钙化与 CT 检测到的钙化相关:与胎球蛋白-A 和 FGF-23 的关系。
J Nephrol. 2011 May-Jun;24(3):313-21. doi: 10.5301/JN.2010.5818.
7
Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.慢性血液透析的糖尿病和非糖尿病患者中成纤维细胞生长因子-23的血浆水平与矿物质代谢
Int Urol Nephrol. 2008;40(4):1067-74. doi: 10.1007/s11255-008-9462-4. Epub 2008 Sep 13.
8
Coronary artery calcifications in children with end-stage renal disease.终末期肾病患儿的冠状动脉钙化
Pediatr Nephrol. 2006 Oct;21(10):1426-33. doi: 10.1007/s00467-006-0159-6. Epub 2006 Jul 4.
9
The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients
.血液透析患者血清骨桥蛋白和FGF 23水平与瓣膜钙化的关系
Clin Nephrol. 2019 Jan;91(1):9-16. doi: 10.5414/CN109505.
10
Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.维持性血液透析终末期肾病患者中,成纤维细胞生长因子-23与心血管钙化的关系。
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):51-60. doi: 10.4103/1319-2442.198127.

引用本文的文献

1
Assessment of Cardiovascular Risks by CT-Derived Calcium Scoring and FGF-23 in Patients with Renal Hyperparathyroidism Undergoing Near-Total Parathyroidectomy and Cinacalcet Therapy: A Prospective Pilot Study.通过CT衍生的钙评分和FGF-23评估接受近全甲状旁腺切除术和西那卡塞治疗的肾性甲状旁腺功能亢进患者的心血管风险:一项前瞻性试点研究。
Indian J Endocrinol Metab. 2025 Jul-Aug;29(4):446-452. doi: 10.4103/ijem.ijem_502_24. Epub 2025 Aug 26.
2
Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease.儿童慢性肾脏病患者的颈动脉内膜中层厚度、成纤维细胞生长因子 23 与矿物质骨代谢紊乱。
BMC Nephrol. 2024 Oct 21;25(1):369. doi: 10.1186/s12882-024-03771-z.
3

本文引用的文献

1
Klotho deficiency causes vascular calcification in chronic kidney disease.Klotho 缺乏导致慢性肾脏病中的血管钙化。
J Am Soc Nephrol. 2011 Jan;22(1):124-36. doi: 10.1681/ASN.2009121311. Epub 2010 Nov 29.
2
Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.血浆成纤维细胞生长因子-23水平与维持性血液透析患者的颈动脉粥样硬化独立相关。
Hemodial Int. 2010 Oct;14(4):425-32. doi: 10.1111/j.1542-4758.2010.00480.x.
3
Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis.
Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.
血清 25-羟维生素 D3、成纤维细胞生长因子 23 和 C1q/肿瘤坏死因子相关蛋白 3 与非透析慢性肾脏病患者冠状动脉钙化的关系。
Ren Fail. 2023 Dec;45(1):2220412. doi: 10.1080/0886022X.2023.2220412.
4
Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.慢性肾脏病对冠状动脉钙化的病理生理学及临床影响
J Cardiovasc Dev Dis. 2023 May 10;10(5):207. doi: 10.3390/jcdd10050207.
5
Arrhythmias in Chronic Kidney Disease.慢性肾脏病中的心律失常
Eur Cardiol. 2022 Mar 7;17:e05. doi: 10.15420/ecr.2021.52. eCollection 2022 Feb.
6
Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis.血液透析患者的铁、冠状动脉钙化和死亡率。
Ren Fail. 2021 Dec;43(1):371-380. doi: 10.1080/0886022X.2021.1880937.
7
Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial.烟酰胺在慢性血液透析患者中作为抗磷药物之外作用的研究:一项单中心、双盲、随机、安慰剂对照试验
Ann Transl Med. 2020 Apr;8(8):530. doi: 10.21037/atm.2020.03.228.
8
Small steps towards the potential of 'preventive' treatment of early phosphate loading in chronic kidney disease patients.慢性肾病患者早期磷负荷“预防性”治疗潜力的小进展。
Clin Kidney J. 2019 Jul 25;12(5):673-677. doi: 10.1093/ckj/sfz082. eCollection 2019 Oct.
9
Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3.碳酸司维拉姆对正常磷血症慢性肾脏病3期患者成纤维细胞生长因子23及脉搏波速度的短期影响
Clin Kidney J. 2019 Mar 25;12(5):678-685. doi: 10.1093/ckj/sfz027. eCollection 2019 Oct.
10
Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病患者冠状动脉钙化的患病率及其与死亡率、心血管事件的关系:系统评价和荟萃分析。
Ren Fail. 2019 Nov;41(1):244-256. doi: 10.1080/0886022X.2019.1595646.
接受长期血液透析的儿科患者的营养不良-炎症-冠状动脉钙化
Hemodial Int. 2010 Jul;14(3):263-9. doi: 10.1111/j.1542-4758.2010.00442.x. Epub 2009 Nov 17.
4
Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.成纤维细胞生长因子 23 与慢性肾脏病患儿的骨代谢
Kidney Int. 2010 Jul;78(2):200-6. doi: 10.1038/ki.2010.107. Epub 2010 Apr 21.
5
The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.肾小球滤过率和年龄对儿童慢性肾脏病患者血清成纤维细胞生长因子 23 水平的影响。
J Clin Endocrinol Metab. 2010 Apr;95(4):1741-8. doi: 10.1210/jc.2009-1576. Epub 2010 Feb 15.
6
The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.FGF23-Klotho 轴:磷酸盐稳态的内分泌调节。
Nat Rev Endocrinol. 2009 Nov;5(11):611-9. doi: 10.1038/nrendo.2009.196.
7
Overview of the FGF23-Klotho axis.FGF23-Klotho 轴概述。
Pediatr Nephrol. 2010 Apr;25(4):583-90. doi: 10.1007/s00467-009-1260-4. Epub 2009 Jul 22.
8
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.血清完整成纤维细胞生长因子 23 与老年人群左心室质量、肥大和几何结构相关。
Atherosclerosis. 2009 Dec;207(2):546-51. doi: 10.1016/j.atherosclerosis.2009.05.013. Epub 2009 May 21.
9
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.成纤维细胞生长因子23与慢性肾脏病左心室肥厚
Circulation. 2009 May 19;119(19):2545-52. doi: 10.1161/CIRCULATIONAHA.108.844506. Epub 2009 May 4.
10
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.磷酸盐喂养诱导尿毒症小鼠动脉中层钙化:血清磷、成纤维细胞生长因子-23和骨桥蛋白的作用。
Kidney Int. 2009 Jun;75(12):1297-1307. doi: 10.1038/ki.2009.83. Epub 2009 Mar 25.